We are live on ! Find out more
ALXN

Alexion Pharmaceuticals
ALXN

Delisted

ALXN was delisted on the 20th of July, 2021.

Back to rankings

406 hedge funds and large institutions have $17.3B invested in Alexion Pharmaceuticals in 2013 Q2 according to their latest regulatory filings, with 406 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

53% more call options, than puts

Call options by funds: $149M | Put options by funds: $97.1M

Holders
406
Holders Change
+406
Holders Change %
–
% of All Funds
13.25%
Holding in Top 10
6
Holding in Top 10 Change
+6
Holding in Top 10 Change %
% of All Funds
0.2%
New
406
Increased
–
Reduced
–
Closed
–
Calls
$149M
Puts
$97.1M
Net Calls
+$51.9M
Net Calls Change
+$51.9M

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
Goldman Sachs
26
Goldman Sachs
New York
$121M +$126M +1,308,171 New
BA
27
BlackRock Advisors
Delaware
$111M +$116M +1,208,392 New
Bank of America
28
Bank of America
North Carolina
$111M +$116M +1,201,789 New
Massachusetts Financial Services
29
Massachusetts Financial Services
Massachusetts
$106M +$111M +1,149,787 New
WRF
30
Waddell & Reed Financial
Kansas
$92.7M +$96.9M +1,005,206 New
UBS AM
31
UBS AM
Illinois
$90.3M +$94.3M +978,596 New
Citadel Advisors
32
Citadel Advisors
Florida
$88.8M +$92.8M +962,772 New
Franklin Resources
33
Franklin Resources
California
$82.3M +$86M +892,220 New
Legal & General Group
34
Legal & General Group
United Kingdom
$75.9M +$79.3M +822,666 New
Adage Capital Partners
35
Adage Capital Partners
Massachusetts
$73.1M +$76.4M +792,500 New
BB
36
BB Biotech
Switzerland
$71.8M +$75M +778,126 New
MAA
37
Managed Account Advisors
New Jersey
$71.1M +$74.3M +771,337 New
Deutsche Bank
38
Deutsche Bank
Germany
$64.3M +$67.2M +697,458 New
Axa
39
Axa
France
$60M +$62.7M +650,466 New
HM
40
HealthCor Management
New York
$60M +$62.6M +650,000 New
Prudential Financial
41
Prudential Financial
New Jersey
$60M +$62.6M +649,926 New
TA
42
Teachers Advisors
New York
$59.3M +$61.9M +642,679 New
New York State Common Retirement Fund
43
New York State Common Retirement Fund
New York
$59.1M +$61.7M +640,300 New
Alkeon Capital Management
44
Alkeon Capital Management
New York
$57.6M +$60.2M +625,000 New
CS
45
Credit Suisse
Switzerland
$54.7M +$57.2M +593,287 New
Millennium Management
46
Millennium Management
New York
$54.1M +$56.5M +586,735 New
Sumitomo Mitsui Trust Group
47
Sumitomo Mitsui Trust Group
Japan
$53.1M +$55.4M +575,273 New
California Public Employees Retirement System
48
California Public Employees Retirement System
California
$48.1M +$50.2M +521,105 New
SAM
49
Sectoral Asset Management
Quebec, Canada
$47.2M +$49.4M +512,108 New
RFS
50
Rockefeller Financial Services
New York
$46.8M +$48.9M +506,975 New
1
2
3 4 5

ALXN Hedge Fund Activity: Q2 2013 in Review

406 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in Alexion Pharmaceuticals (ALXN) for Q2 2013, worth a combined $17.3B.

Buyers outnumbered sellers: 406 funds opened new ALXN positions and 0 closed out — a net gain of 406 holders — while 0 added to existing stakes and 0 trimmed.

  • 406 institutional investors held Alexion Pharmaceuticals (ALXN) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $17.3B of Alexion Pharmaceuticals stock for Q2 2013.
  • 406 funds opened new Alexion Pharmaceuticals positions in Q2 2013 and 0 closed out, a net change of +406 holders.

Based on aggregated 13F filings for Q2 2013.